Interestingly, tumours derived from H-KO cells bearing shRNAs against DYRK2, exhibited a statistically significant reduction in tumour weight compared with all scrambled control cells (parental and H-KO) (Figure 5F). The gene discussed is DYRK2; the disease is neoplasm.